Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


America's Top-Selling Prescription Drugs a Who's Who of Blockbusters

Mar 4, 2006 | Newsinferno News Staff

According to a recent article in Forbes.com (2/27/06) that was based on figures obtained from IMS Health, a healthcare information company, the top 20 prescription drugs in the U.S. in 2005, with combined sales of $64.6 billion, were as follow:

1.    LIPITOR – Pfizer – Treats high cholesterol: $8.4 billion

2.    ZOCOR – Merck –Treats high cholesterol: $4.4 billion

3.    NEXIUM – AstraZeneca – Treats heartburn: $4.4 billion

4.    PREVACID – Abbott & Takeda – Treats heartburn: $3.8 billion

5.    ADVAIR DISKUS – GlaxoSmithKline – Treats asthma: $3.6 billion

6.    PLAVIX – Bristol-Meyers Squibb & Sanofi-Aventis – Treats heart disease $3.5 billion

7.    ZOLOFT – Pfizer – Treats depression: $3.1 billion

8.    EPOGEN – Amgen – Treats anemia: $3.0 billion

9.    PROCRIT – Johnson & Johnson – Treats anemia: $3.0 billion

10.    ARANESP – Amgen – Treats anemia: $2.8 billion

11.    ENBREL – Amgen & Wyeth – Treats rheumatoid arthritis: $2.7 billion

12.    NORVASC – Pfizer – Treats high blood pressure: $2.6 billion

13.    SEROQUEL – AstraZeneca – Treats schizophrenia: $2.6 billion

14.    EFFEXOR XR – Wyeth – Treats depression: $2.6 billion

15.    ZYPREXA – Eli Lilly – Treats: schizophrenia: $2.5 billion

16.    SINGULAIR – Merck – Treats asthma and allergies: $2.5 billion

17.    PROTONIX – Wyeth – Treats heartburn: $2.4 billion

18.    RISPERDAL – Johnson & Johnson – Treats schizophrenia: $2.3 billion

19.    NEULASTA – Amgen – Treats chemotherapy side effects: $2.2 billion

20.    REMICADE – Johnson & Johnson – Treats rheumatoid arthritis: $2.2 billion


Related articles Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo